Crossmark

Regulatory challenges of personalized medicine in the real world: are the right patients being treated with CD19-targeting CAR T-cells?

Published Online: 2026-04-27

Authors

Sebe, Attila https://orcid.org/0000-0001-7814-5144
Hernani, Rafael

Müller-Berghaus, Jan https://orcid.org/0009-0006-2555-0959
License Information

Text and Data Mining valid from 2026-04-27

Version of Record valid from 2026-04-27
More Information

Article History

Received: 4 December 2025

Revised: 20 April 2026

Accepted: 21 April 2026

First Online: 27 April 2026

Disclosure and competing interests statement

: The authors declare no competing interests.

Document is current